POLX vs. RUA, IHC, MHC, SUN, DEMG, BELL, IUG, LLAI, FDBK, and GENF
Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include RUA Life Sciences (RUA), Inspiration Healthcare Group (IHC), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), Belluscura (BELL), Intelligent Ultrasound Group (IUG), LungLife AI (LLAI), Feedback (FDBK), and Genflow Biosciences (GENF). These companies are all part of the "medical" sector.
Polarean Imaging (LON:POLX) and RUA Life Sciences (LON:RUA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk.
RUA Life Sciences has higher revenue and earnings than Polarean Imaging. RUA Life Sciences is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.
Polarean Imaging has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, RUA Life Sciences has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.
Polarean Imaging received 23 more outperform votes than RUA Life Sciences when rated by MarketBeat users. Likewise, 67.65% of users gave Polarean Imaging an outperform vote while only 0.00% of users gave RUA Life Sciences an outperform vote.
23.4% of Polarean Imaging shares are owned by institutional investors. Comparatively, 20.7% of RUA Life Sciences shares are owned by institutional investors. 28.0% of Polarean Imaging shares are owned by company insiders. Comparatively, 18.8% of RUA Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Polarean Imaging has a net margin of 0.00% compared to RUA Life Sciences' net margin of -100.05%. RUA Life Sciences' return on equity of -40.56% beat Polarean Imaging's return on equity.
In the previous week, Polarean Imaging's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.
Summary
Polarean Imaging beats RUA Life Sciences on 8 of the 13 factors compared between the two stocks.
Get Polarean Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Polarean Imaging Competitors List
Related Companies and Tools
